In addition, we assessed the potential of this nanotherapeutic system by testing the ability of Au-antimiR-155 NCs to upregulate TLR3 expression and promote apoptosis in cultured HCC cells. The gene discussed is TLR3; the disease is hepatocellular carcinoma.